Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7147

1.

Treatment for Clostridium difficile infection in adults--reply.

Rao K, Bagdasarian N, Malani PN.

JAMA. 2015 May 19;313(19):1976. doi: 10.1001/jama.2015.3674. No abstract available.

PMID:
25988472
2.

Treatment for Clostridium difficile infection in adults.

Dai C, Jiang M, Sun MJ.

JAMA. 2015 May 19;313(19):1975-6. doi: 10.1001/jama.2015.3671. No abstract available.

PMID:
25988470
3.

Treatment for Clostridium difficile infection in adults.

McDonald EG, Lee TC.

JAMA. 2015 May 19;313(19):1974-5. doi: 10.1001/jama.2015.3668. No abstract available.

PMID:
25988469
4.

Selected aspects of Clostridium difficile infection.

Mehlich A, Górska S, Gamian A, Myc A.

Postepy Hig Med Dosw (Online). 2015 May 5;69(0):598-611. doi: 10.5604/17322693.1151340.

PMID:
25983298
5.

Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, Van Schooneveld TC, Pardi DS, Ramos A, Barron MA, Chen H, Villano S.

JAMA. 2015 May 5;313(17):1719-27. doi: 10.1001/jama.2015.3725.

PMID:
25942722
6.

A Combination of Three Fully-Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of C. difficile in the Hamster Model.

Anosova NG, Cole LE, Li L, Zhang J, Brown AM, Mundle S, Zhang J, Ray S, Ma F, Garrone P, Bertraminelli N, Kleanthous H, Anderson SF.

Clin Vaccine Immunol. 2015 Apr 29. pii: CVI.00763-14. [Epub ahead of print]

PMID:
25924765
7.

The Clostridium difficile Protease Cwp84 Modulates both Biofilm Formation and Cell-Surface Properties.

Pantaléon V, Soavelomandroso AP, Bouttier S, Briandet R, Roxas B, Chu M, Collignon A, Janoir C, Vedantam G, Candela T.

PLoS One. 2015 Apr 29;10(4):e0124971. doi: 10.1371/journal.pone.0124971. eCollection 2015.

8.

Interaction of the Clostridium difficile Binary Toxin CDT and its Host Cell Receptor LSR.

Hemmasi S, Czulkies BA, Schorch B, Veit A, Aktories K, Papatheodorou P.

J Biol Chem. 2015 Apr 16. pii: jbc.M115.650523. [Epub ahead of print]

9.

Toward a true bacteriotherapy for Clostridium difficile infection.

Rupnik M.

N Engl J Med. 2015 Apr 16;372(16):1566-8. doi: 10.1056/NEJMcibr1500270. No abstract available.

PMID:
25875262
10.

Clostridium difficile infection.

Leffler DA, Lamont JT.

N Engl J Med. 2015 Apr 16;372(16):1539-48. doi: 10.1056/NEJMra1403772. Review. No abstract available.

PMID:
25875259
11.

[Clostridium difficile colitis].

Eckert C, Lalande V, Barbut F.

Rev Prat. 2015 Jan;65(1):21-5. Review. French.

PMID:
25842418
12.

Pseudomembranous colitis.

Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC.

Dis Mon. 2015 May;61(5):181-206. doi: 10.1016/j.disamonth.2015.01.006. Epub 2015 Mar 11. Review. No abstract available.

PMID:
25769243
13.

Case of cytomegalovirus colitis in an immunocompetent patient: a rare cause of abdominal pain and diarrhea in the elderly.

Harano Y, Kotajima L, Arioka H.

Int J Gen Med. 2015 Mar 3;8:97-100. doi: 10.2147/IJGM.S63771. eCollection 2015.

14.

Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B.

Eckert C, Emirian A, Le Monnier A, Cathala L, De Montclos H, Goret J, Berger P, Petit A, De Chevigny A, Jean-Pierre H, Nebbad B, Camiade S, Meckenstock R, Lalande V, Marchandin H, Barbut F.

New Microbes New Infect. 2014 Nov 8;3:12-7. doi: 10.1016/j.nmni.2014.10.003. eCollection 2015 Jan.

15.

Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells.

Huang T, Perez-Cordon G, Shi L, Li G, Sun X, Wang X, Wang J, Feng H.

Pathog Dis. 2015 Apr;73(3). pii: ftv008. doi: 10.1093/femspd/ftv008. Epub 2015 Jan 27.

PMID:
25743476
16.

Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.

Zacharioudakis IM, Zervou FN, Pliakos EE, Ziakas PD, Mylonakis E.

Am J Gastroenterol. 2015 Mar;110(3):381-90; quiz 391. doi: 10.1038/ajg.2015.22. Epub 2015 Mar 3. Review.

PMID:
25732416
17.

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.

Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A.

Aliment Pharmacol Ther. 2015 May;41(9):835-43. doi: 10.1111/apt.13144. Epub 2015 Mar 1.

PMID:
25728808
18.

Fecal microbiota transplantation: the case of immunocompromised patients.

Matuchansky C.

Am J Med. 2015 Mar;128(3):e21. doi: 10.1016/j.amjmed.2014.06.020. No abstract available.

PMID:
25707891
19.

Body mass index as a predictor of postoperative complications in loop ileostomy closure after rectal resection in Japanese patients.

Saito Y, Takakura Y, Hinoi T, Egi H, Tashiro H, Ohdan H.

Hiroshima J Med Sci. 2014 Dec;63(4):33-8.

PMID:
25707091
20.

Clostridium difficile infection: a Serbian single-center experience.

Korac M, Milosevic I, Markovic M, Popovic N, Ilic M, Markovic A, Nikolic J, Jevtovic D.

J Infect Dev Ctries. 2015 Feb 19;9(2):136-40. doi: 10.3855/jidc.5060.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk